These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 22762358

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sumatriptan succinate : pharmacokinetics of different formulations in clinical practice.
    Lionetto L, Negro A, Casolla B, Simmaco M, Martelletti P.
    Expert Opin Pharmacother; 2012 Nov; 13(16):2369-80. PubMed ID: 23013035
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Tepper SJ, Dodick DW, Schmidt PC, Kellerman DJ.
    Headache; 2019 Apr; 59(4):509-517. PubMed ID: 30698272
    [Abstract] [Full Text] [Related]

  • 7. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
    Goadsby PJ, Yates R.
    Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [Abstract] [Full Text] [Related]

  • 12. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ, Charlesworth BR, Green J, Färkkilä M, Diener HC, Hansen SB, Gawel M, INDEX Study Group.
    Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
    [Abstract] [Full Text] [Related]

  • 13. Migraine: diagnosis, management, and new treatment options.
    Gallagher RM, Cutrer FM.
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S58-73. PubMed ID: 11859906
    [Abstract] [Full Text] [Related]

  • 14. Zolmitriptan provides effective migraine relief in adolescents.
    Linder SL, Dowson AJ.
    Int J Clin Pract; 2000 Sep; 54(7):466-9. PubMed ID: 11070573
    [Abstract] [Full Text] [Related]

  • 15. Intranasal zolmitriptan for the treatment of acute migraine.
    Tepper SJ, Chen S, Reidenbach F, Rapoport AM.
    Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M, Aschoff J, May A, Charlesworth BR, REALIZE Study Team.
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [Abstract] [Full Text] [Related]

  • 18. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlöf CG, Mateos V, Dowson AJ, Raets I, Cunha L, Färkkilä M, Manzoni GC.
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild.
    Klapper J, Lucas C, Røsjø Ø, Charlesworth B, ZODIAC study group.
    Cephalalgia; 2004 Nov; 24(11):918-24. PubMed ID: 15482352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.